In Italy, the role of a nurse in cancer research is beginning to develop, but instruments developed to delineate the dimensions of the Italian clinical trials nursing role are lacking. This study aimed to translate into Italian the Clinical Trials Nursing Questionnaire (CTNQ) and assess its content validity, internal consistency, and stability reliability. 
a copy of the questionnaire was given again to a subgroup of 10 research nurses.
The pretest and posttest scores were compared using . coefficient. The comparison of the target language version with the original version allowed us to consider the translation of CTNQ as acceptable. The analyses revealed a Cronbach ! coefficient of .98 for the frequency scale and .96 for the importance scale. The overall . coefficient was 0.98 for the frequency scale and 0.99 for the importance scale. The CTNQ is a valid and reliable instrument for the assessment of the research nurse's role in Italy.
n Background
Cancer is a major concern all over the world. In 2006, a total number of 250,000 Italians have been diagnosed with cancer, and about 130,000 of them have died of cancer disease. 1 Despite the fact that approximately 50% of cancer patients still die of the disease, considerable progress has taken place in cancer therapy that translates into remarkable improvements in the life expectancy and quality of life of these patients.
It is noteworthy that this progress results from the efforts of scientists involved in the preclinical phases of the research, healthcare professionals who carry on clinical trials, and patients who accept to be enrolled in these trials. Clinical trials of new cancer therapies are a necessary step in the process of translating scientific discoveries and technical advancements into procedures and products that offer the prospect of a longer survival and a better quality of life. 2 In Italy, the number of clinical trials has increased considerably over the last years; data from the National Monitoring Centre for Clinical Trials (Osservatorio Nazionale sulla Sperimentazione Clinica dei Medicinali) have shown that approximately 3,500 new clinical trials were registered between the years 2000 and 2005. Most of these studies are multicentered (81.3%), international (66.5%), and sponsored by pharmaceutical companies (74%). Approximately oneVthird of them are oncologic trials related to antineoplastic and immunomodulatory drugs. 3 In the last 15 years, the complexity of clinical trials has greatly increased, both because of changes in its methodology and bureaucratic constraints imposed by new regulations. Clinical trial processes need to be completed in the right way, at the right time, by the right specialist or specialty service, and in compliance with the good clinical practice guidelines. 4, 5 Therefore, the necessity to have qualified personnel conducting the clinical trials is mandatory. In Italy, this condition is already fulfilled for the physicians but not yet completely for the nurses.
In Italy, the role of the nurse in cancer research has just started expanding, contrary to other European and American countries where the specific role of the oncology nurse in clinical trials has been defined years ago and has grown together with the clinical research.
As described by many authors 6Y17 and oncology professional organizations such as the Oncology Nursing Society, the clinical trial nurse (CTN) is a well-recognized key member of the team for the implementation and overall management of the trial. He or she is conversant with all aspects of the protocol and can put theory into practice, assisting the patient from the early phase of screening and directing his or her recruitment in the trial according to the eligibility criteria. The CTN is often directly involved in scheduling the patients for all steps of treatment and followup foreseen in the trial. Other responsibilities include organizing the collection of biological samples, developing data collection tools, educating the components of the interdisciplinary team and the patients, alerting the principal investigator to significant trends in the data, acting as the referent for the staff and the patients, preparing reports, and ensuring the quality and reliability of the data.
Survey instruments aimed at delineating and describing the role of the CTN are missing in Italy.
The primary objectives of the present work were to translate into Italian language the Clinical Trials Nursing Questionnaire (CTNQ) 5 and assess its content validity, internal consistency, and reliability. At the end of these tasks, a new instrument would be available to the Italian scientific community to better integrate into daily clinical practice the different roles that CTN may have in the oncology clinical setting.
n Methods
The CTNQ was developed in the United States by Ehrenberger and Lillington 5 in 2004 to measure the frequency and importance of clinical trials nursing activities. The original CTNQ is a selfVadministered paper-and-pencil tool consisting of 12 sections, for a total of 154 items. The first 8 sections of the questionnaire (120 items) assess the complex role components of the professional nurse who uses the nursing process to support the clinical research. Activities and responsibilities that nurse may assume in a variety of clinical research role are scaled by the respondent for frequency and importance. The respondent indicates the frequency with which he or she has performed the activity during the previous year using a scale of 0 (never, not part of my role), 1 (once or twice), 2 (occasionally, as needed), 3 (repeatedly, at various times), and 4 (extremely frequently). The respondent indicates the importance of the activity for the safety and effectiveness of the practice of clinical trials nursing using a scale from 0 (not important) to 4 (very important). Section 9 (10 items) asks for the respondent's perceptions and experiences related to the role of a nurse involved in clinical research. For this section, the respondent answers using a 5-point Likert-type scale from 1 (strongly agree) to 5 (strongly disagree). If the item is not applicable to the current role, then ''not applicable'' is a possible response. Section 10 (11 items) contains questions regarding the professional characteristics of the nursing role (eg, highest degree completed, years of experience, certifications). Section 11 (9 items) consists of questions related to the employing organization (eg, primary work setting, title of the position assigned, opportunity for advancement). Section 12, the final section of the survey (4 items), contains questions concerning the demographic characteristics of the professional nurse. 5 For the original validation of the questionnaire, a total of 69 CTNs were recruited from different geographic regions of the United States and Canada. The content validity was assessed using an expert judge panel of 6 members; analysis of the instrument's reliability and internal consistency revealed a Cronbach ! coefficient of .92 for the frequency scale and .95 for the importance scale. A comparison of the test-retest reliability was conducted within a 2-week interval in a sample of 40 oncology CTNs out of the 69 participants, and a coefficient of .88 was obtained for the frequency scale and .92 for the importance scale. 5 
Linguistic and Content Validation
The Italian validation of the questionnaire has followed the same methodology that had been applied to the original one. Linguistic and content validation followed an internationally accepted methodology consisting of 3 steps: a forward translation, a backward translation, and a review by experts in clinical trials nursing.
Each step is meant at improving the quality of the translation with respect to the conceptual equivalence between the original and the translated questionnaires and easing the comprehension of the questionnaire content by the nurse respondents.
The aim of the forward translation was to translate the 154 items of the original CTNQ into Italian language and produce a version that was semantically and conceptually as close as possible to the original questionnaire. One of the authors who is a native Italian speaker, proficient in English, and living in the target country performed this step. The backward translation was carried out as follows: one qualified translator who is a native English speaker, proficient in Italian, and living in Italy translated the items generated from the forward translation back into American English. The translation discrepancies were corrected in the Italian version to generate a draft version of the CTNQ ready for being assessed by experts.
Thereafter, 2 experts in clinical trials nursing independently checked the content validity of the translated CTNQ and its cultural adaptation using a cognitive debriefing process. Finally, the translated CTNQ was administered to 5 nurses who are attending a clinical research nurse course to assess, as a pilot test, the face validity for readability, clarity, length, and comprehension.
An additional pilot test was also carried out to assess the nurses' level of understanding.
Internal Consistency and Test-Retest Reliability
Analysis of the instrument's reliability and internal consistency was computed by administering the translated CTNQ to a sample of 30 research nurses coming from different Italian districts. Internal consistency was determined by checking the components of the questionnaire against each other using Cronbach !. 18 To determine the testVretest reliability of the CTNQ, which provides an estimate of the instrument stability over time, a copy of the questionnaire was given again 2 weeks later to a subgroup of 10 clinical trials nurses. The comparison between the pretest and posttest scores allowed the computation of the . coefficient, 19 ,20 a statistics appropriate for testing whether agreement exceeds chance. Statistical analyses were performed through SAS for Windows version 9.1 (SAS institute Cary, North Carolina, USA).
n Results
During the process of cultural adaptation performed by the expert panel, major attention was focused on possible problems related to the expressions used rather than the understanding of the actual questions. In addition, the expert panel decided to remove the following items because Italian national health system always covers the cost of patient care: item 13, ''assess the protocol for reimbursement of patient care costs by third-party health plans,'' in section 1 and item 11, ''verify coverage of patient care costs by third-party health plans for potential subjects,'' in section 3. Sections 10, 11, and 12 referring to professional, organizational, and demographic characteristics, respectively, were modified according to the Italian settings. Comments which emerged from the 2 pilot tests were taken into account and included into the final Italian version. Thus, the final Italian CTNQ is composed of 12 sections, for a total of 149 items ( Table 1 ).
All the 34 CTNs censused in the White Book of Italian Oncology data (Il Libro Bianco dell'Oncologia Italiana) 21 were contacted by e-mail or telephone, and 30 out of them completed the questionnaire. The White Book of Italian Oncology represents a useful tool containing updated information collected by the National Association of Medical Oncology (Associazione Italiana di Oncologia Medica) through the census of the Italian cancer centers. Table 2 and Table 3 show the demographic characteristics and the professional nursing role characteristics of the study population, respectively.
The mean age of the respondents was 38 years old. Most of them were female, lived in north of Italy, and had an informal primary education in clinical research (eg, on the job training, self-taught, etc).
With respect to educational attainment, 21 (70%) of the respondents involved in this study had a regional diploma; 3 of these respondents (10%) held also a master's degree in oncology.
The analyses for the internal consistency revealed a Cronbach ! coefficient of .98 for the frequency scale and .96 for the importance scale. The overall . coefficient for the reproducibility (test-retest reliability) of the questionnaire was 0.98 for the frequency scale and 0.99 for the importance scale.
n Discussion Clinical trials require a skilled team as they test new treatment regimens or combinations of treatments as well as new side effects that may occur when testing new target therapies. Dealing with the complications of chemotherapy has always been an area of special concern for cancer nurses.
In the clinical research field in European and American countries, the CTN is responsible for coordinating activities associated with clinical trials, covering both administrative and clinical duties. Integration of nurses into clinical research teams has been emerging as a new role for Italian nurses who are able to participate at the team-shared aims of enrolling patients in the study and maintaining protocol integrity and also ensure the safety of the patient. In addition, CTN can act as the patient advocate and can play a vital link role between clinic practice area and clinic research area.
In Italy, the nursing training has been undergoing a significant transformation over the last years, and new skills nowadays embrace the nurses' role. Clinical trials nursing is becoming an emerging profession. Therefore, it is important to establish guidelines and standards of practice for this new professional role. These guidelines and standards could define the preparation for this role both at the basic and the postgraduate levels. The CTNQ is a promising and appropriate instrument for assessing the research nurses' role, in particular for the oncology clinical research nurses. The translation process into the Italian language and the following validation steps partly could answer the statement of Ehrenberger who recommended an additional testing of her tool in a larger population of nurses working in the research settings. 5 Firstly, the comparison of the target language version with the original one allowed us to consider the translation of CTNQ as acceptable and successful.
The results of the survey also allowed us to declare the validity of the Italian version of the CTNQ developed by Ehrenberger and Lillington to measure the frequency and importance of clinical trials nursing activities. Indeed, the analysis of the internal consistency revealed a Cronbach ! coefficient as high as .98 for the frequency scale and .96 for the importance scale, whereas for a newly developed instrument, an ! coefficient of .70 is considered acceptable. 20 The overall . coefficient for the reproducibility was 0.98 for the frequency scale and 0.99 for the importance scale, thus demonstrating an excellent reliability of the Italian CTNQ.
At present time in Italy, the need to delineate the CTN role is becoming stronger to gain recognition within the Italian public healthcare system. To this purpose, a group of Italian CTNVGruppo Infermieri Ricerca ClinicaVhas been lately constituted.
The new validated survey instrument we present here will be used in a national survey aimed at assessing the role of the Italian clinical trials nurse. The results of this survey could also offer support to delineate the framework of the general competencies required for basic and advanced levels of practice for nurses involved in clinical trials and to judge the quality of the activities performed by the Italian CTN until now. 
